Carole Dembek

811 total citations · 1 hit paper
42 papers, 555 citations indexed

About

Carole Dembek is a scholar working on Pulmonary and Respiratory Medicine, Psychiatry and Mental health and Physiology. According to data from OpenAlex, Carole Dembek has authored 42 papers receiving a total of 555 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Pulmonary and Respiratory Medicine, 14 papers in Psychiatry and Mental health and 10 papers in Physiology. Recurrent topics in Carole Dembek's work include Chronic Obstructive Pulmonary Disease (COPD) Research (16 papers), Inhalation and Respiratory Drug Delivery (14 papers) and Bipolar Disorder and Treatment (10 papers). Carole Dembek is often cited by papers focused on Chronic Obstructive Pulmonary Disease (COPD) Research (16 papers), Inhalation and Respiratory Drug Delivery (14 papers) and Bipolar Disorder and Treatment (10 papers). Carole Dembek collaborates with scholars based in United States, United Kingdom and Spain. Carole Dembek's co-authors include Aditi Kadakia, Rachel Halpern, Bartolomé R. Celli, G. Rhys Williams, Noam Y. Kirson, Qi Fan, R Becker, Xiaoli Niu, Leigh Ann White and Elise M. Pelletier and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and CHEST Journal.

In The Last Decade

Carole Dembek

38 papers receiving 532 citations

Hit Papers

The Economic Burden of Schizophrenia in the United States 2022 2026 2023 2024 2022 25 50 75 100
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. The Economic Burden of Schizophrenia in the United States
    2022 110 citations Aditi Kadakia, Qi Fan et al. The Journal of Clinical Psychiatry profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Carole Dembek United States 11 163 147 113 99 50 42 555
Federica Bellone Italy 17 121 0.7× 55 0.4× 88 0.8× 56 0.6× 19 0.4× 47 769
Louise Heron United Kingdom 11 63 0.4× 260 1.8× 56 0.5× 218 2.2× 26 0.5× 27 669
Marko A. Mychaskiw United States 12 266 1.6× 92 0.6× 30 0.3× 15 0.2× 21 0.4× 32 485
Stephanie Nikolaus Netherlands 13 309 1.9× 64 0.4× 106 0.9× 41 0.4× 28 0.6× 27 786
Zafer Güney Türkiye 7 121 0.7× 40 0.3× 126 1.1× 53 0.5× 21 0.4× 21 437
K Le Lay France 15 712 4.4× 173 1.2× 31 0.3× 105 1.1× 54 1.1× 44 1.1k
Ercolie R. Bossema Netherlands 13 113 0.7× 84 0.6× 34 0.3× 50 0.5× 28 0.6× 20 488
Lynn H. Deutsch United States 8 250 1.5× 92 0.6× 42 0.4× 67 0.7× 21 0.4× 8 485
Linnea Widman Sweden 16 110 0.7× 31 0.2× 70 0.6× 66 0.7× 75 1.5× 45 763
Amy E. Sanders United States 11 141 0.9× 33 0.2× 46 0.4× 64 0.6× 56 1.1× 18 444

Countries citing papers authored by Carole Dembek

Since Specialization
Citations

This map shows the geographic impact of Carole Dembek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carole Dembek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carole Dembek more than expected).

Fields of papers citing papers by Carole Dembek

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carole Dembek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carole Dembek. The network helps show where Carole Dembek may publish in the future.

Co-authorship network of co-authors of Carole Dembek

This figure shows the co-authorship network connecting the top 25 collaborators of Carole Dembek. A scholar is included among the top collaborators of Carole Dembek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carole Dembek. Carole Dembek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Semwal, Monika, Gideon Aweh, S. Duke Han, et al.. (2024). Healthcare Resource Use and Cost Associated with Negative Symptoms of Schizophrenia. CNS Spectrums. 29(5). 504–505. 1 indexed citations
2.
Mahler, Donald A., Xiaoli Niu, Kathleen L. Deering, & Carole Dembek. (2022). Prospective Evaluation of Exacerbations Associated with Suboptimal Peak Inspiratory Flow Among Stable Outpatients with COPD. SHILAP Revista de lepidopterología. 10 indexed citations
3.
Kadakia, Aditi, et al.. (2022). The Economic Burden of Schizophrenia in the United States. The Journal of Clinical Psychiatry. 83(6). 110 indexed citations breakdown →
4.
Niu, Xiaoli, Carole Dembek, Qi Fan, et al.. (2022). The impact of lurasidone on functioning and indirect costs in adults with bipolar depression: a post-hoc analysis. Journal of Medical Economics. 25(1). 152–159. 4 indexed citations
5.
Niu, Xiaoli, Carole Dembek, Kimberly K. Laubmeier, et al.. (2021). Hospitalization Risk for Adults with Bipolar I Disorder Treated with Oral Atypical Antipsychotics as Adjunctive Therapy with Mood Stabilizers: A Retrospective Analysis of Medicaid Claims Data. Current Therapeutic Research. 94. 100629–100629. 4 indexed citations
6.
Niu, Xiaoli, Yanmei Liu, Jason Shafrin, et al.. (2021). Hospitalization Risk Among Adults with Bipolar I Disorder Treated with Oral Atypical Antipsychotics: A Long-Term Data Analysis of Medicaid Claims Data. CNS Spectrums. 26(2). 172–173. 1 indexed citations
7.
Kadakia, Aditi, et al.. (2021). Healthcare resource utilization and quality of life by cognitive impairment in patients with schizophrenia. Schizophrenia Research Cognition. 28. 100233–100233. 15 indexed citations
8.
Davidson, H. Edward, Lisa Han, Theresa I. Shireman, et al.. (2021). Clinical Characterization of Nursing Facility Residents With Chronic Obstructive Pulmonary Disease. The Senior Care Pharmacist. 36(5). 248–257. 2 indexed citations
9.
Murray, Lindsey, et al.. (2020). Clinically Important Deterioration Among Patients with Chronic Obstructive Pulmonary Disease (COPD) Treated with Nebulized Glycopyrrolate: A Post Hoc Analysis of Pooled Data from Two Randomized, Double-Blind, Placebo-Controlled Studies. SHILAP Revista de lepidopterología.
10.
Stephenson, Judith J., et al.. (2020). <p>Observational Real-World Study to Assess Clinical Characteristics and Device Satisfaction in Patients with COPD Treated with Glycopyrrolate/eFlow<sup>®</sup> CS</p>. International Journal of COPD. Volume 15. 1713–1727. 6 indexed citations
11.
Keshishian, Allison, Lin Xie, Carole Dembek, & Hüseyin Yüce. (2019). Reduction in Hospital Readmission Rates Among Medicare Beneficiaries With Chronic Obstructive Pulmonary Disease: A Real-world Outcomes Study of Nebulized Bronchodilators. Clinical Therapeutics. 41(11). 2283–2296. 7 indexed citations
12.
Mahler, Donald A., Edward Kerwin, Lindsey Murray, & Carole Dembek. (2019). The Impact of Twice-Daily Indacaterol/Glycopyrrolate on the Components of Health-Related Quality of Life and Dyspnea in Patients with Moderate-to-Severe Chronic Obstructive Pulmonary Disease. Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation. 6(4). 308–320. 3 indexed citations
13.
Celli, Bartolomé R., et al.. (2019). Inhalation Technique Errors with Metered-Dose Inhalers Among Patients with Obstructive Lung Diseases: A Systematic Review and Meta-Analysis of U.S. Studies. Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation. 6(3). 267–280. 54 indexed citations
14.
Celli, Bartolomé R., et al.. (2019). Exacerbations, Health Resource Utilization, and Costs Among Medicare Beneficiaries with Chronic Obstructive Pulmonary Disease Treated with Nebulized Arformoterol Following a Respiratory Event. Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation. 6(4). 297–307.
15.
Shireman, Theresa I., et al.. (2019). ASSESSMENT OF PEAK INSPIRATORY FLOW RATES AND MEDICAL MANAGEMENT OF COPD IN NURSING FACILITY RESIDENTS. CHEST Journal. 156(4). A1748–A1749. 1 indexed citations
16.
17.
Rajagopalan, Krithika, Lisa Bloudek, Jessica Marvel, Carole Dembek, & Abhishek Kavati. (2018). Cost-effectiveness of twice-daily indacaterol/glycopyrrolate inhalation powder for the treatment of moderate to severe COPD in the US. International Journal of COPD. Volume 13. 3867–3877. 8 indexed citations
18.
Becker, R, Carole Dembek, Leigh Ann White, & Louis P. Garrison. (2012). The cost offsets and cost–effectiveness associated with pegylated drugs: a review of the literature. Expert Review of Pharmacoeconomics & Outcomes Research. 12(6). 775–793. 20 indexed citations
19.
Becker, R & Carole Dembek. (2011). Effects of Cohort Selection on the Results of Cost-Effectiveness Analysis of Disease-Modifying Drugs for Relapsing-Remitting Multiple Sclerosis. Journal of Managed Care Pharmacy. 17(5). 377–381. 15 indexed citations
20.
Dembek, Carole, et al.. (2010). PND7 ECONOMIC IMPACT OF PERSISTENCE TO DISEASE MODIFYING THERAPIES FOR THE TREATMENT OF MULTIPLE SCLEROSIS. Value in Health. 13(7). A388–A389. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Federica Bellone Breakdown of academic impact, for papers by Louise Heron Breakdown of academic impact, for papers by Marko A. Mychaskiw Breakdown of academic impact, for papers by Stephanie Nikolaus Breakdown of academic impact, for papers by Zafer Güney Breakdown of academic impact, for papers by K Le Lay Breakdown of academic impact, for papers by Ercolie R. Bossema Breakdown of academic impact, for papers by Lynn H. Deutsch Breakdown of academic impact, for papers by Linnea Widman Breakdown of academic impact, for papers by Amy E. Sanders
Rankless by CCL
2026